2m 2m 2m 2m 2m 2m 2m
ETON PHARM (ETON)
NASDAQ
$69.12+$0.72 (+1.05%)
Price as of Nov 12, 2026 8:37 AM EST- $2.0BMarket Cap
- 291.75%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ETON PHARM (ETON)
$69.12+$0.72 (+1.05%)
ETON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $68.40 | ||
Change | +$0.86 (+1.27%) | ||
Open | $66.94 | ||
High | $70.64 | ||
Low | $64.74 | ||
Previous Close | $67.54 | ||
Volume | 1,133,716 | ||
30-Day Average Volume | 550,753 | ||
1-Week Change | 34.86% | ||
1-Month Change | 23.89% | ||
1-Year Change | 291.75% | ||
3-Year Change | 1,681.25% | ||
5-Year Change | 1,304.52% | ||
Fundamentals | |||
Shares Outstanding | 28.8M | ||
Total Assets | $157.3M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $57.9M | ||
Net Income | $35.2M | ||
Free Cash Flow | $35.2M | ||
EBIT | $23.0M | ||
EBITDA | $24.5M | ||
Net Working Capital | $42.7M | ||
EPS | $1.06 | ||
Enterprise Value/EBITDA | 79 | ||
Enterprise Value/Revenue | 33 | ||
P/B | 23 | ||
P/E | 65 | ||
PEG | 0 | ||
Price/Free Cash Flow | 56 | ||
Price/Operating Cash Flow | 56 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue